Bank Of Montreal Sarepta Therapeutics, Inc. Transaction History

Bank Of Montreal

$202 Billion
Q4 2024

A detailed history of Bank Of Montreal transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 156,418 shares of SRPT stock, worth $15.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

156,418

Previous 185,592 15.72%

Holding current value

$15.2 Million

Previous $23.2 Million 17.96%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$104.54 - $137.94 $3.05 Million - $4.02 Million	-29,174 Reduced 15.72%	156,418 $19 Million
Q3 2024 Nov 13, 2024	BUY	$124.33 - $156.75 $957,589 - $1.21 Million	7,702 Added 4.33%	185,592 $23.2 Million
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $118,996 - $172,042	1,050 Added 0.59%	177,890 $28.1 Million
Q1 2024 May 13, 2024	BUY	$93.7 - $141.53 $2.28 Million - $3.44 Million	24,290 Added 15.92%	176,840 $22.9 Million
Q4 2023 Feb 08, 2024	SELL	$67.31 - $124.76 $8.05 Million - $14.9 Million	-119,663 Reduced 43.96%	152,550 $14.7 Million
Q3 2023 Nov 01, 2023	BUY	$102.5 - $123.59 $17.9 Million - $21.5 Million	174,299 Added 178.01%	272,213 $33 Million
Q2 2023 Aug 02, 2023	BUY	$106.4 - $157.19 $4.53 Million - $6.69 Million	42,565 Added 76.9%	97,914 $11.2 Million
Q1 2023 Jun 13, 2024	SELL	$117.53 - $155.99 $16.7 Million - $22.1 Million	-141,847 Reduced 80.21%	34,993 $4.82 Million
Q4 2022 Feb 01, 2023	SELL	$100.86 - $132.13 $479,589 - $628,278	-4,755 Reduced 7.91%	55,349 $7.17 Million
Q3 2022 Nov 10, 2022	SELL	$75.71 - $119.24 $3.6 Million - $5.66 Million	-47,492 Reduced 44.14%	60,104 $6.76 Million
Q2 2022 Aug 11, 2022	SELL	$62.69 - $88.44 $23.4 Million - $33.1 Million	-373,770 Reduced 77.65%	107,596 $8.15 Million
Q1 2022 May 12, 2022	BUY	$63.15 - $90.42 $29.1 Million - $41.7 Million	460,768 Added 2236.96%	481,366 $37.8 Million
Q4 2021 Feb 11, 2022	SELL	$77.28 - $99.42 $20.2 Million - $26 Million	-261,711 Reduced 92.7%	20,598 $1.87 Million
Q3 2021 Nov 12, 2021	BUY	$65.97 - $92.48 $18.3 Million - $25.7 Million	277,393 Added 5642.66%	282,309 $25.6 Million
Q2 2021 Aug 12, 2021	BUY	$69.38 - $86.75 $341,072 - $426,463	4,916 New	4,916 $395,000

Others Institutions Holding SRPT

# of Institutions

535

Shares Held

87.4M

Call Options Held

1.55M

Put Options Held

1.35M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $8.51B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account